2016 International Congress

Tuesday, June 21, 2016

12:30pm-2:00pm

Reliability and responsiveness of in-clinic and at-home app-based bradykinesia assessment

D.A. Heldman, E. Urrea Mendoza, L.C. Lovera, D.A. Schmerler, J.P. Giuffrida, A.J. Espay, J.X.O. Garcia, M.E. Mohammad, M.C.U. McFarlane, H.H. Fernandez (Cleveland, OH, USA)

Technology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Resetting tremor by single pulse transcranial magnetic stimulation at the motor cortex and the cerebellum in essential tremor and dystonic tremor

P. Panyakaew, H.J. Cho, P. Srivanitchapoom, M. Hallett (Bethesda, MD, USA)

Tremor  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Response to thermal and pain stimulation and genetic variance for pain in patients with Parkinson’s disease – Are they all related?

A. Khlebtovsky, R. Dabby, Y. Rodity, I. Steiner, R. Djaldetti (Petach Tikva, Israel)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Risk of movement disorders with antipsychotic drugs in patients with schizophrenia or depressive disorders

M.V. Rey, L. Molina, B. Recinos, B. Paz, M. Rovelo, F.E. Rodriguez Elias, J. Calderon, A. Arellano, S. Pomata, S. Perez-Lloret, CA-APD Study Team (Buenos Aires, Argentina)

Hyperkinetic Movement Disorders, RLS, Sleep

12:30pm-2:00pm

Risk prediction modeling in Parkinson’s disease using genetic and environmental/lifestyle factors

C.M. Lill, Y.H. Chuang, J. Hansen, P.C. Lee, N. Greene, C. Klein, H. Binder, B. Ritz, L. Bertram (Lübeck, Germany)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Role of dopamine and GABA during subthalamic and pallidal deep brain stimulation: Evidence of dopamine release during subthalamic Deep Brain Stimulation

A. Nakajima, Y. Shimo, T. Uka, N. Hattori (Tokyo, Japan)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Role of macroautophagy in regulating microglia-mediated neuroinflammation and dopaminergic neuron injury

M. Jin, L. Hu, C. Liu (Suzhou, People's Republic of China)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Roles of combined functional catechol-o-methyltransferase genotypes in Chinese Parkinson’s disease: A cross-sectional survey

Y. Qian, X. Yang, S. Xu, J. Liu, Q. Xiao (Shanghai, People's Republic of China)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Safety and efficacy of escalating doses of incobotulinumtoxinA (400-800U): Increasing improvements in disability due to multifocal upper- and lower-limb spasticity

J. Wissel, D. Bensmail, B. Rubin, A. Scheschonka, O. Simon, D.M. Simpson (Berlin, Germany)

Spasticity  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Saliva swallowing frequency measured using 24-hours ambulatory impedance-pH monitoring in patients with Parkinson’s disease and drooling

J.G. Kalf, S. Scholten, W. Hopman (Nijmegen, Netherlands)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2